TY - JOUR
T1 - Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles
T2 - I. Impact of plasticizer on film properties and dissolution
AU - Krull, Scott M.
AU - Patel, Hardik V.
AU - Li, Meng
AU - Bilgili, Ecevit
AU - Davé, Rajesh N.
N1 - Publisher Copyright:
© 2016 Elsevier B.V.
PY - 2016/9/20
Y1 - 2016/9/20
N2 - Recent studies have demonstrated polymer films to be a promising platform for delivery of poorly water-soluble drug particles. However, the impact of critical material attributes, for example plasticizer, on the properties of and drug release from such films has yet to be investigated. In response, this study focuses on the impact of plasticizer and plasticizer concentration on properties and dissolution rate of polymer films loaded with poorly water-soluble drug nanoparticles. Glycerin, triacetin, and polyethylene glycol were selected as film plasticizers. Griseofulvin was used as a model Biopharmaceutics Classification System class II drug and hydroxypropyl methylcellulose was used as a film-forming polymer. Griseofulvin nanoparticles were prepared via wet stirred media milling in aqueous suspension. A depression in film glass transition temperature was observed with increasing plasticizer concentration, along with a decrease in film tensile strength and an increase in film elongation, as is typical of plasticizers. However, the type and amount of plasticizer necessary to produce strong yet flexible films had no significant impact on the dissolution rate of the films, suggesting that film mechanical properties can be effectively manipulated with minimal impact on drug release. Griseofulvin nanoparticles were successfully recovered upon redispersion in water regardless of plasticizer or content, even after up to 6 months' storage at 40 °C and 75% relative humidity, which contributed to similar consistency in dissolution rate after 6 months' storage for all films. Good content uniformity (< 4% R.S.D. for very small film sample size) was also maintained across all film formulations.
AB - Recent studies have demonstrated polymer films to be a promising platform for delivery of poorly water-soluble drug particles. However, the impact of critical material attributes, for example plasticizer, on the properties of and drug release from such films has yet to be investigated. In response, this study focuses on the impact of plasticizer and plasticizer concentration on properties and dissolution rate of polymer films loaded with poorly water-soluble drug nanoparticles. Glycerin, triacetin, and polyethylene glycol were selected as film plasticizers. Griseofulvin was used as a model Biopharmaceutics Classification System class II drug and hydroxypropyl methylcellulose was used as a film-forming polymer. Griseofulvin nanoparticles were prepared via wet stirred media milling in aqueous suspension. A depression in film glass transition temperature was observed with increasing plasticizer concentration, along with a decrease in film tensile strength and an increase in film elongation, as is typical of plasticizers. However, the type and amount of plasticizer necessary to produce strong yet flexible films had no significant impact on the dissolution rate of the films, suggesting that film mechanical properties can be effectively manipulated with minimal impact on drug release. Griseofulvin nanoparticles were successfully recovered upon redispersion in water regardless of plasticizer or content, even after up to 6 months' storage at 40 °C and 75% relative humidity, which contributed to similar consistency in dissolution rate after 6 months' storage for all films. Good content uniformity (< 4% R.S.D. for very small film sample size) was also maintained across all film formulations.
KW - Dissolution rate
KW - Drug nanoparticles
KW - Mechanical properties
KW - Pharmaceutical films
KW - Physical stability
KW - Plasticizer
UR - http://www.scopus.com/inward/record.url?scp=84978881219&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84978881219&partnerID=8YFLogxK
U2 - 10.1016/j.ejps.2016.07.005
DO - 10.1016/j.ejps.2016.07.005
M3 - Article
C2 - 27402100
AN - SCOPUS:84978881219
SN - 0928-0987
VL - 92
SP - 146
EP - 155
JO - European Journal of Pharmaceutical Sciences
JF - European Journal of Pharmaceutical Sciences
ER -